ABT-288 Uses, Dosage, Side Effects and more
ABT-288 is under investigation in clinical trial NCT01018875 (Efficacy and Safety Study of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's Disease).
| Trade Name | ABT-288 |
| Generic | ABT-288 |
| Type | |
| Formula | C23H24N4O |
| Weight | Average: 372.472 Monoisotopic: 372.195011409 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
